Sofispas D 80mg/250mg Tablet
Marketer
Sofi Healthcare Llp
Salt Composition
Drotaverine (80mg) + Mefenamic Acid (250mg)
Overview Sofispas D 80mg/250mg Tablet
Abdominal pain relief is provided by the combined medication, Sofispas D 80mg/250mg Tablet. This formulation effectively lessens abdominal pain, distension, discomfort, and spasms by relaxing the gastrointestinal tract's musculature. It simultaneously inhibits pain-inducing neurotransmitters. Dosage and treatment duration for Sofispas D 80mg/250mg Tablets should strictly follow your physician's instructions, varying based on individual response and condition severity. Complete the prescribed course; premature cessation may result in symptom recurrence and condition exacerbation. Inform your healthcare provider of all concurrent medications, as interactions are possible. Common side effects include diarrhea, nausea, vomiting, abdominal pain, dry mouth, appetite loss, thirst, and heartburn; most are transient. Report any concerning side effects immediately. Dizziness and drowsiness are also potential effects; avoid driving or mentally demanding tasks until their impact is understood. Alcohol consumption should be avoided due to potential dizziness exacerbation. Consult your doctor before use if pregnant, planning pregnancy, breastfeeding, or if you have kidney or liver impairment to ensure appropriate dosage.
Primary Ingredients of Sofispas D 80mg/250mg Tablet
No information provided. Please provide the text you wish to be rephrased.
Uses of Sofispas D 80mg/250mg Tablet
Managing abdominal discomfort
Major Benefits of Sofispas D 80mg/250mg Tablet:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Sofispas D 80mg/250mg Tablet with a meal.
Common Side effects of Sofispas D 80mg/250mg Tablet:
- Nausea
- Vomiting
- Diarrhea
- Dryness in mouth
- Heartburn
- Vertigo
- Insomnia (difficulty in sleeping)
- Hypotension (low blood pressure)
- Fast heart rate
- Sweating
- Constipation
- Increased liver enzymes
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Purpura
- Agranulocytosis (deficiency of granulocytes in the blood)
- Breathlessness
- Ringing in ear
- Abdominal pain
- Flatulence
- Indigestion
- Stomach inflammation
- Confusion
- Depression
How to use Sofispas D 80mg/250mg Tablet:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the 80mg/250mg Sofispas D Tablet whole; avoid chewing, crushing, or fracturing it. Administer this medication with a meal.
How Sofispas D 80mg/250mg Tablet works:
The combined analgesic Sofispas D 80mg/250mg Tablet offers relief from abdominal pain and cramping. This formulation unites drotaverine, a muscle relaxant targeting abdominal spasms by inhibiting smooth muscle contractions, with mefenamic acid, a non-steroidal anti-inflammatory drug (NSAID). Mefenamic acid's mechanism involves suppressing inflammatory mediators responsible for abdominal discomfort and swelling.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol alongside Sofispas D 80mg/250mg tablets poses a safety risk.
PregnancyCONSULT YOUR DOCTOR
The use of Sofispas D 80mg/250mg tablets during pregnancy may pose risks. While human research is limited, animal studies indicate potential harm to the fetus. A physician will assess the potential benefits against any risks prior to prescribing. Seek medical advice before taking this medication.
Breast feedingCONSULT YOUR DOCTOR
Data on Sofispas D 80mg/250mg Tablet use while breastfeeding is lacking. Seek medical advice from your physician.
DrivingUNSAFE
Driving ability may be impaired by Sofispas D 80mg/250mg Tablets, a potential side effect of the medication, including dizziness.
KidneyCAUTION
Patients with impaired kidney function should exercise caution when using Sofispas D 80mg/250mg tablets, potentially requiring dosage modification under medical supervision. Sofispas D 80mg/250mg tablets are contraindicated in individuals with severe kidney disease.
LiverCAUTION
Patients with hepatic impairment should use Sofispas D 80mg/250mg tablets cautiously; dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Sofispas D 80mg/250mg Tablet :
Should you forget a Sofispas D 80mg/250mg Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Sofispas D 80mg/250mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Gastrointestinal system |
3,018 People bought this recently